$1.33 Billion is the total value of Eversept Partners, LP's 85 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 98.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| AMRN | Buy | AMARIN CORP PLCspons adr new | $104,929,103 | +34.6% | 16,896,796 | +6.0% | 7.89% | -13.7% |
| UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $81,381,706 | +16.9% | 486,529 | +6.1% | 6.12% | -25.1% |
| ARKG | New | ARK ETF TRgenomic rev etf | $71,599,076 | – | 806,932 | +100.0% | 5.38% | – |
| ALXN | Buy | ALEXION PHARMACEUTICALS INC | $71,253,461 | +21.2% | 465,983 | +23.9% | 5.36% | -22.3% |
| HZNP | Buy | HORIZON THERAPEUTICS PUB L | $64,010,046 | +64.8% | 695,459 | +31.0% | 4.81% | +5.6% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDsponsored ads | $50,253,884 | +89.5% | 4,354,756 | +58.5% | 3.78% | +21.4% |
| AZN | Buy | ASTRAZENECA PLCsponsored adr | $49,337,902 | +15.8% | 992,315 | +16.4% | 3.71% | -25.8% |
| GSK | Buy | GLAXOSMITHKLINE PLCcall | $41,189,829 | +217.4% | 1,154,100 | +227.3% | 3.10% | +103.5% |
| ASND | Buy | ASCENDIS PHARMA A/Ssponsored adr | $40,193,419 | +28.8% | 311,867 | +66.7% | 3.02% | -17.4% |
| DHR | Buy | DANAHER CORPORATION | $39,991,245 | +42.4% | 177,534 | +40.5% | 3.01% | -8.7% |
| SPY | New | SPDR S&P 500 ETF TRput | $39,633,000 | – | 100,000 | +100.0% | 2.98% | – |
| TGTX | Sell | TG THERAPEUTICS INC | $36,756,790 | -18.2% | 762,589 | -11.7% | 2.76% | -47.6% |
| XLRN | New | ACCELERON PHARMA INC | $32,815,043 | – | 241,981 | +100.0% | 2.47% | – |
| CYH | Buy | COMMUNITY HEALTH SYS INC NEW | $32,526,876 | +34088.1% | 2,405,834 | +18688.2% | 2.44% | +22127.3% |
| AMRX | Buy | AMNEAL PHARMACEUTICALS INC | $32,004,380 | +494.4% | 4,755,480 | +303.6% | 2.41% | +280.7% |
| GSK | Sell | GLAXOSMITHKLINE PLCsponsored adr | $31,057,290 | -11.8% | 852,206 | -10.0% | 2.34% | -43.4% |
| NVST | Sell | ENVISTA HOLDINGS CORPORATION | $29,893,507 | +2.9% | 732,684 | -14.9% | 2.25% | -34.1% |
| AVTR | Buy | AVANTOR INC | $27,743,494 | +7.1% | 958,987 | +4.2% | 2.09% | -31.4% |
| OCDX | New | ORTHO CLINICAL DIAGNOSTICS H | $26,535,024 | – | 1,375,228 | +100.0% | 2.00% | – |
| FATE | Sell | FATE THERAPEUTICS INC | $26,529,112 | -27.0% | 321,760 | -19.5% | 1.99% | -53.2% |
| MCK | New | MCKESSON CORP | $23,986,604 | – | 122,983 | +100.0% | 1.80% | – |
| ANTM | Sell | ANTHEM INC | $22,934,033 | +8.6% | 63,892 | -2.9% | 1.72% | -30.4% |
| QGEN | Buy | QIAGEN NV | $22,140,365 | +24.4% | 454,721 | +35.0% | 1.66% | -20.3% |
| CTLT | Sell | CATALENT INC | $17,177,535 | -40.9% | 163,114 | -41.6% | 1.29% | -62.2% |
| BDX | New | BECTON DICKINSON & CO | $16,627,326 | – | 68,383 | +100.0% | 1.25% | – |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $16,552,456 | +86.1% | 242,172 | +133.4% | 1.24% | +19.3% |
| HCA | Buy | HCA HEALTHCARE INC | $16,085,931 | +483.8% | 85,409 | +409.8% | 1.21% | +274.3% |
| ZGNX | Sell | ZOGENIX INC | $16,069,430 | -11.6% | 823,229 | -9.5% | 1.21% | -43.4% |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS IN | $15,501,950 | +10.3% | 345,717 | +40.4% | 1.16% | -29.3% |
| VRTX | New | VERTEX PHARMACEUTICALS INCcall | $12,893,400 | – | 60,000 | +100.0% | 0.97% | – |
| TARO | Buy | TARO PHARMACEUTICAL INDS LTD | $12,122,878 | +8.4% | 164,378 | +8.0% | 0.91% | -30.5% |
| ALNY | New | ALNYLAM PHARMACEUTICALS INC | $11,427,495 | – | 80,937 | +100.0% | 0.86% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $10,836,000 | – | 420,000 | +100.0% | 0.82% | – |
| HUM | New | HUMANA INC | $10,438,077 | – | 24,839 | +100.0% | 0.78% | – |
| ITCI | Sell | INTRA CELLULAR THERAPIES INC | $10,198,917 | -10.0% | 300,587 | -15.6% | 0.77% | -42.3% |
| ARGX | New | ARGENX SEsponsored adr | $9,882,646 | – | 35,886 | +100.0% | 0.74% | – |
| ARKK | New | ARK ETF TRinnovation etf | $9,835,900 | – | 82,000 | +100.0% | 0.74% | – |
| MGLN | MAGELLAN HEALTH INC | $9,762,228 | +12.6% | 104,700 | 0.0% | 0.73% | -27.8% | |
| CI | New | CIGNA CORP NEW | $9,669,600 | – | 40,000 | +100.0% | 0.73% | – |
| MNKD | New | MANNKIND CORP | $8,488,301 | – | 2,165,383 | +100.0% | 0.64% | – |
| AFMD | Buy | AFFIMED N V | $8,274,880 | +47.4% | 1,046,129 | +8.4% | 0.62% | -5.6% |
| DXCM | Buy | DEXCOM INC | $6,735,328 | +636.7% | 18,741 | +657.8% | 0.51% | +372.9% |
| GH | New | GUARDANT HEALTH INC | $6,143,705 | – | 40,247 | +100.0% | 0.46% | – |
| NVAX | New | NOVAVAX INC | $6,068,990 | – | 33,473 | +100.0% | 0.46% | – |
| NTRA | New | NATERA INC | $5,858,858 | – | 57,700 | +100.0% | 0.44% | – |
| CNC | New | CENTENE CORP DEL | $5,823,479 | – | 91,120 | +100.0% | 0.44% | – |
| SRGA | New | SURGALIGN HOLDINGS INC | $5,754,729 | – | 2,639,784 | +100.0% | 0.43% | – |
| KDMN | Sell | KADMON HLDGS INC | $5,341,433 | -46.6% | 1,373,119 | -43.0% | 0.40% | -65.7% |
| ARKG | New | ARK ETF TRput | $5,048,737 | – | 56,900 | +100.0% | 0.38% | – |
| MCRB | Sell | SERES THERAPEUTICS INC | $4,432,533 | -45.8% | 215,276 | -35.6% | 0.33% | -65.3% |
| LMNX | New | LUMINEX CORP DEL | $4,332,705 | – | 135,471 | +100.0% | 0.33% | – |
| IMVT | New | IMMUNOVANT INC | $3,692,135 | – | 230,183 | +100.0% | 0.28% | – |
| FPRX | Sell | FIVE PRIME THERAPEUTICS INC | $3,513,858 | -1.2% | 93,280 | -55.4% | 0.26% | -36.7% |
| CNC | New | CENTENE CORP DELcall | $3,195,500 | – | 50,000 | +100.0% | 0.24% | – |
| AMRN | Sell | AMARIN CORP PLCcall | $2,737,368 | -56.5% | 440,800 | -65.7% | 0.21% | -72.0% |
| ENSG | Sell | ENSIGN GROUP INC | $2,711,897 | -82.2% | 28,883 | -86.1% | 0.20% | -88.6% |
| SRDX | Buy | SURMODICS INC | $2,686,089 | +49.4% | 47,906 | +16.0% | 0.20% | -4.3% |
| AHAC | New | ALPHA HEALTHCARE ACQUISTN COcl a | $2,588,652 | – | 239,026 | +100.0% | 0.20% | – |
| LXRX | New | LEXICON PHARMACEUTICALS INC | $2,410,181 | – | 410,593 | +100.0% | 0.18% | – |
| A | Buy | AGILENT TECHNOLOGIES INC | $1,940,284 | +229.0% | 15,261 | +206.6% | 0.15% | +111.6% |
| ISRG | New | INTUITIVE SURGICAL INC | $1,908,682 | – | 2,583 | +100.0% | 0.14% | – |
| HSKA | Sell | HESKA CORP | $1,859,798 | -83.2% | 11,040 | -85.5% | 0.14% | -89.2% |
| FREQ | New | FREQUENCY THERAPEUTICS INCput | $1,839,200 | – | 193,600 | +100.0% | 0.14% | – |
| XGN | Buy | EXAGEN INC | $1,827,648 | +69.7% | 104,437 | +28.0% | 0.14% | +8.7% |
| NVAX | New | NOVAVAX INCcall | $1,813,100 | – | 10,000 | +100.0% | 0.14% | – |
| PRTA | Sell | PROTHENA CORP PLC | $1,722,604 | -29.5% | 68,575 | -66.3% | 0.13% | -54.5% |
| KROS | New | KEROS THERAPEUTICS INC | $1,700,688 | – | 27,631 | +100.0% | 0.13% | – |
| XENT | New | INTERSECT ENT INC | $1,574,122 | – | 75,389 | +100.0% | 0.12% | – |
| New | TELIGENT INC NEW | $1,555,412 | – | 2,500,260 | +100.0% | 0.12% | – | |
| New | CONFORMIS INC | $1,526,558 | – | 1,541,978 | +100.0% | 0.12% | – | |
| LQDA | New | LIQUIDIA CORPORATION | $1,345,027 | – | 500,010 | +100.0% | 0.10% | – |
| IQV | Buy | IQVIA HLDGS INC | $1,143,582 | +56.2% | 5,921 | +44.9% | 0.09% | 0.0% |
| CHWY | New | CHEWY INCcl a | $1,109,701 | – | 13,100 | +100.0% | 0.08% | – |
| RAD | Sell | RITE AID CORP | $1,105,352 | -86.9% | 54,025 | -89.8% | 0.08% | -91.6% |
| IFRX | New | INFLARX NV | $1,047,673 | – | 268,634 | +100.0% | 0.08% | – |
| CABA | New | CABALETTA BIO INC | $853,024 | – | 76,849 | +100.0% | 0.06% | – |
| GOCO | Buy | GOHEALTH INC | $805,429 | +98.6% | 68,899 | +132.1% | 0.06% | +27.1% |
| IMMP | New | IMMUTEP LTDsponsored ads | $767,178 | – | 249,895 | +100.0% | 0.06% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INCcall | $645,000 | – | 25,000 | +100.0% | 0.05% | – |
| APLS | Buy | APELLIS PHARMACEUTICALS INC | $553,539 | +153.6% | 12,900 | +238.1% | 0.04% | +61.5% |
| QDEL | Sell | QUIDEL CORP | $528,607 | -92.7% | 4,132 | -89.8% | 0.04% | -95.3% |
| OTIC | New | OTONOMY INCcall | $505,920 | – | 198,400 | +100.0% | 0.04% | – |
| New | APTOSE BIOSCIENCES INC | $478,000 | – | 80,000 | +100.0% | 0.04% | – | |
| RGEN | New | REPLIGEN CORP | $277,617 | – | 1,428 | +100.0% | 0.02% | – |
| FREQ | New | FREQUENCY THERAPEUTICS INCcall | $94,800 | – | 10,000 | +100.0% | 0.01% | – |
| CYTK | Exit | CYTOKINETICS INCcall | $0 | – | -10,000 | -100.0% | -0.02% | – |
| ZYME | Exit | ZYMEWORKS INC | $0 | – | -5,405 | -100.0% | -0.03% | – |
| MRUS | Exit | MERUS N V | $0 | – | -14,445 | -100.0% | -0.03% | – |
| LCI | Exit | LANNET INCcall | $0 | – | -63,900 | -100.0% | -0.04% | – |
| KALV | Exit | KALVISTA PHARMACEUTICALS INC | $0 | – | -18,925 | -100.0% | -0.04% | – |
| TARA | Exit | PROTARA THERAPEUTICS INC | $0 | – | -36,310 | -100.0% | -0.10% | – |
| Exit | CATABASIS PHARMACEUTICALS IN | $0 | – | -522,042 | -100.0% | -0.13% | – | |
| CNCE | Exit | CONCERT PHARMACEUTICALS INC | $0 | – | -103,829 | -100.0% | -0.15% | – |
| AUTL | Exit | AUTOLUS THERAPEUTICS PLCspon ads | $0 | – | -154,981 | -100.0% | -0.16% | – |
| OTIC | Exit | OTONOMY INC | $0 | – | -253,283 | -100.0% | -0.19% | – |
| ONCT | Exit | ONCTERNAL THERAPEUTICS INC | $0 | – | -344,090 | -100.0% | -0.20% | – |
| ANAB | Exit | ANAPTYSBIO INC | $0 | – | -88,334 | -100.0% | -0.22% | – |
| SESN | Exit | SESEN BIO INC | $0 | – | -1,559,824 | -100.0% | -0.25% | – |
| SNY | Exit | SANOFIsponsored adr | $0 | – | -68,138 | -100.0% | -0.39% | – |
| BCRX | Exit | BIOCRYST PHARMACEUTICALS INC | $0 | – | -491,852 | -100.0% | -0.43% | – |
| ALT | Exit | ALTIMMUNE INC | $0 | – | -380,000 | -100.0% | -0.50% | – |
| OXFD | Exit | OXFORD IMMUNOTEC GLOBAL PLC | $0 | – | -307,742 | -100.0% | -0.63% | – |
| AUPH | Exit | AURINIA PHARMACEUTICALS INC | $0 | – | -604,368 | -100.0% | -0.98% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INC | $0 | – | -138,644 | -100.0% | -2.77% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMARIN CORP PLC | 21 | Q3 2023 | 12.5% |
| DANAHER CORPORATION | 21 | Q3 2023 | 8.1% |
| AFFIMED N V | 20 | Q3 2023 | 0.9% |
| ARGENX SE | 19 | Q3 2023 | 2.0% |
| GSK PLC | 18 | Q2 2022 | 13.1% |
| ASCENDIS PHARMA A/S | 18 | Q1 2022 | 7.7% |
| SANOFI | 18 | Q4 2022 | 7.2% |
| ENSIGN GROUP INC | 18 | Q1 2022 | 8.6% |
| CENTENE CORP DEL | 18 | Q3 2023 | 1.5% |
| ZOGENIX INC | 17 | Q4 2021 | 12.4% |
View Eversept Partners, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Cabaletta Bio, Inc. | February 14, 2023 | 282,874 | 1.0% |
| Teligent, Inc.Sold out | February 16, 2021 | 0 | 0.0% |
| Teligent, Inc. | February 14, 2020 | 4,501,799 | 8.4% |
View Eversept Partners, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
| 13F-HR/A | 2023-11-08 |
View Eversept Partners, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.